U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06907160) titled 'Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer' on Dec. 04, 2024.
Brief Summary: 1. To explore tissue-based biomarkers to select patients who do not respond to neoadjuvant immunotherapy (non-responders) at the point of diagnosis
2. To explore blood-based non-invasive biomarkers to predict pathological complete response (pCR) before surgery
Study Start Date: Aug. 07, 2024
Study Type: OBSERVATIONAL
Condition:
Clinical Stage II to III Non-Small Cell Lung Cancer
Recruitment Status: RECRUITING
Sponsor: Yonsei University
Published by HT Di...